Axumin Positron Emission Tomography: Novel Agent for Prostate Cancer Biochemical Recurrence

Prostate cancer remains one of the top common cancers in terms of incidence and cancer-related deaths. Approximately 1/3 rd cases develop biochemical recurrence during surveillance post-definite therapy. Multiple imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI) (including multiparametric prostate MRI), bone scan, and positron emission tomography (PET) using different tracers are being used for the...